Zusammenfassung
In den letzten Jahren fanden eine intensive Diskussion um den Nutzen der Amblyopiefrüherkennung und -therapie, große prospektive randomisierte kontrollierte Studien zur Amblyopietherapie und erste Studien, die neue technischen Möglichkeiten zur Messung der effektiven Okklusionszeit nutzen, statt. Hierdurch ergibt sich eine bessere Studienlage zur Amblyopietherapie.
Abstract
In recent years there has been a lively discussion on the benefits of early detection and treatment of amblyopia, as well as large prospective randomized controlled studies. Furthermore, we now have the opportunity to measure effective occlusion time. This leads to a better scientific base for discussion of amblyopia therapy.
Literatur
Leitlinie Nr. 26a: Amblyopie. In: Arens CD, Bertram B (Hrsg) (1998) Praxisorientierte Handlungsleitlinien für Diagnose und Therapie in der Augenheilkunde des Berufsverbands der Augenärzte e.V. BVA, Düsseldorf, S 4–6
Awan M, Proudlock FA, Gottlob I (2005) A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci 46: 1435–1439
BenEzra O, Herzog R, Cohen E et al. (2007) Liquid crystal glasses: feasibility and safety of a new modality for treating amblyopia. Arch Ophthalmol 125: 580–581
Choong YF, Lukman H, Martin S, Laws DE (2004) Childhood amblyopia treatment: psychosocial implications for patients and primary carers. Eye 18: 369–375
Cotter SA, Edwards AR, Arnold RW et al. (2007) Treatment of strabismic amblyopia with refractive correction. Am J Ophthalmol 143: 1060–1063
Cotter SA, Edwards AR, Wallace DK et al. (2006) Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology 113: 895–903
Fresina M, Dickmann A, Salerni A et al. (2008) Effect of oral CDP-choline on visual function in young amblyopic patients. Graefes Arch Clin Exp Ophthalmol 246: 143–150
Fronius M, Chopovska Y, Nolden J et al. (2006) Occlusion treatment for amblyopia: assessing the performance of the electronic occlusion dose monitor. Strabismus 14: 65–70
Fronius M, Cirina L, Kuhli C et al. (2006) Training the adult amblyopic eye with „perceptual learning“ after vision loss in the non-amblyopic eye. Strabismus 14: 75–79
Hertle RW, Scheiman MM, Beck RW et al. (2007) Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years. Arch Ophthalmol 125: 655–659
Holmes JM, Beck RW, Kraker RT et al. (2003) Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol 121: 1625–1632
Holmes JM, Kraker RT, Beck RW et al. (2003) A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 110: 2075–2087
Kämpf U, Muchamedjarow F, Seiler T (2001) Unterstützende Amblyopiebehandlung durch Computerspiele mit Hintergrundstimulation: Eine placebokontrollierte Studie. Klin Monatsbl Augenheilkd 218: 243–250
Loudon SE, Fronius M, Looman CW et al. (2006) Predictors and a remedy for noncompliance with amblyopia therapy in children measured with the occlusion dose monitor. Invest Ophthalmol Vis Sci 47: 4393–4400
Michaelides M, Bunce C, Adams GG (2007) Glaucoma following congenital cataract surgery–the role of early surgery and posterior capsulotomy. BMC Ophthalmol 7: 13
Nilsso J (2007) The negative impact of amblyopia from a population perspective: untreated amblyopia almost doubles the lifetime risk of bilateral visual impairment. Br J Ophthalmol 91: 1417–1418
Pediatric Eye Disease Investigator Group (2002) A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 120: 268–278
Polat U, Ma-Naim T, Belkin M, Sagi D (2004) Improving vision in adult amblyopia by perceptual learning. Proc Natl Acad Sci U S A 101: 6692–6697
Repka MX, Beck RW, Holmes JM et al. (2003) A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 121: 603–611
Repka MX, Wallace DK, Beck RW et al. (2005) Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 123: 149–157
Scheiman MM, Hertle RW, Beck RW et al. (2005) Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol 123: 437–447
Stewart CE, Moseley MJ, Fielder AR, Stephens DA (2004) Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol 88: 1552–1556
Stewart CE, Moseley MJ, Stephens DA, Fielder AR (2004) Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci 45: 3048–3054
Stewart CE, Stephens DA, Fielder AR, Moseley MJ (2007) Objectively monitored patching regimens for treatment of amblyopia: randomised trial. BMJ 335: 707–713
Van Leeuwen R, Eijkemans MJ, Vingerling JR et al. (2007) Risk of bilateral visual impairment in individuals with amblyopia: the Rotterdam study. Br J Ophthalmol 91: 1450–1451
Vishwanath M, Cheong-Leen R, Taylor D et al. (2004) Is early surgery for congenital cataract a risk factor for glaucoma? Br J Ophthalmol 88: 905–910
Wallace DK, Edwards AR, Cotter SA et al. (2006) A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology 113: 904–912
Webber AL, Wood JM, Gole GA, Brown B (2008) The effect of amblyopia on fine motor skills in children. Invest Ophthalmol Vis Sci 49: 594–603
Williams C, Horwood J, Northstone K et al. (2006) The timing of patching treatment and a child’s wellbeing. Br J Ophthalmol 90: 670–671
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ehrt, O. Neues zur Amblyopietherapie. Ophthalmologe 105, 494–498 (2008). https://doi.org/10.1007/s00347-008-1730-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-008-1730-2